Sort   by:  
 Page size 
UnknownProtease-Activated Receptor 1 as Therapeutic Target in Breast, Lung, and Ovarian Cancer: Pepducin Approach.
Not available
S-EPMC6121574 | biostudies-literature
UnknownIdentification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy.
Not available
S-EPMC2917243 | biostudies-literature
UnknownTargeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin.
Not available
S-EPMC5087736 | biostudies-literature
UnknownPlatelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site.
Not available
S-EPMC2807741 | biostudies-literature
UnknownTrace amine-associated receptor 1 (TAAR1) promotes anti-diabetic signaling in insulin-secreting cells.
Not available
S-EPMC6433058 | biostudies-literature
UnknownSuppression of Heart Failure With PAR1 Pepducin Technology in a Pressure Overload Model in Mice.
Not available
S-EPMC10592519 | biostudies-literature
UnknownA novel protease-activated receptor-1 interactor, Bicaudal D1, regulates G protein signaling and internalization.
Not available
S-EPMC2857018 | biostudies-literature
UnknownAllosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor Mimetics.
Not available
S-EPMC4505487 | biostudies-literature
UnknownSelective blockade of matrix metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer.
Not available
S-EPMC3966518 | biostudies-literature
UnknownNoncanonical matrix metalloprotease-1-protease-activated receptor-1 signaling triggers vascular smooth muscle cell dedifferentiation and arterial stenosis.
Not available
S-EPMC3743483 | biostudies-literature
Sort   by:  
 Page size